Literature DB >> 29144996

New roles and controls of mast cells.

Eric Espinosa1, Salvatore Valitutti2.   

Abstract

Mast cells are innate immune cells implicated in immune surveillance and defense. They are filled with secretory granules where a vast array of molecules endowed with multiple biological activities are stored. The process of granule secretion, named degranulation, is a tightly controlled biological phenomenon that allows mast cells to rapidly and efficiently release bioactive mediators in response to extracellular stimuli. MC degranulation allows fighting pathogens, limiting envenomation and contributes to tissue homeostasis. However, it is also a potentially harmful response that plays a key role in the development of allergy and inflammatory diseases. Recent findings revealed that MC degranulation is a complex modular process that can be controlled at multiple levels. First, mast cells can decode different activation stimuli into two main patterns of degranulation that differently impact inflammatory responses. Second, mast cells in contact with antibody-opsonized cells or parasites form antibody-dependent degranulatory synapse for dedicated secretion and defense. Third, IL-33 fine-tunes FcR-mediated degranulation at the single cell level. Together these recent findings show how mast cells adapt their degranulation responses to environmental cues and highlight the remarkable functional plasticity of these cells.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29144996     DOI: 10.1016/j.coi.2017.10.012

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  16 in total

1.  Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Gvindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Iuliia Dubova; Gema Giler; Shelby Herr; Shankar S Iyer; Asgar Zaheer
Journal:  Mol Neurobiol       Date:  2018-06-18       Impact factor: 5.590

2.  Mast cell peptidases (carboxypeptidase A and chymase)-mediated hydrolysis of human angiotensin-(1-12) substrate.

Authors:  Sarfaraz Ahmad; Kendra N Wright; Xuming Sun; Leanne Groban; Carlos M Ferrario
Journal:  Biochem Biophys Res Commun       Date:  2019-08-26       Impact factor: 3.575

Review 3.  Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics.

Authors:  David J Wilkinson; Maria Del Carmen Arques; Carmen Huesa; Andrew D Rowan
Journal:  Br J Pharmacol       Date:  2018-03-30       Impact factor: 8.739

4.  Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways.

Authors:  Yihua Piao; Jingzhi Jiang; Zhiguang Wang; Chongyang Wang; Shan Jin; Li Li; Liangchang Li; Hongmei Piao; Zhehu Jin; Lianhua Zhu; Guanghai Yan
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-30       Impact factor: 2.629

Review 5.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

6.  Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.

Authors:  Andrés López-Cortés; Santiago Guerrero; Esteban Ortiz-Prado; Verónica Yumiceba; Antonella Vera-Guapi; Ángela León Cáceres; Katherine Simbaña-Rivera; Ana María Gómez-Jaramillo; Gabriela Echeverría-Garcés; Jennyfer M García-Cárdenas; Patricia Guevara-Ramírez; Alejandro Cabrera-Andrade; Lourdes Puig San Andrés; Doménica Cevallos-Robalino; Jhommara Bautista; Isaac Armendáriz-Castillo; Andy Pérez-Villa; Andrea Abad-Sojos; María José Ramos-Medina; Ariana León-Sosa; Estefanía Abarca; Álvaro A Pérez-Meza; Karol Nieto-Jaramillo; Andrea V Jácome; Andrea Morillo; Fernanda Arias-Erazo; Luis Fuenmayor-González; Luis Abel Quiñones; Nikolaos C Kyriakidis
Journal:  Front Pharmacol       Date:  2022-03-29       Impact factor: 5.810

7.  Mast Cell Protease 7 Promotes Angiogenesis by Degradation of Integrin Subunits.

Authors:  Devandir A de Souza Junior; Carolina Santana; Gabriel V Vieira; Constance Oliver; Maria Celia Jamur
Journal:  Cells       Date:  2019-04-12       Impact factor: 6.600

8.  Gomisin M2 Inhibits Mast Cell-Mediated Allergic Inflammation via Attenuation of FcεRI-Mediated Lyn and Fyn Activation and Intracellular Calcium Levels.

Authors:  Hima Dhakal; Soyoung Lee; Eun-Nam Kim; Jin Kyeong Choi; Min-Jong Kim; Jinjoo Kang; Young-Ae Choi; Moon-Chang Baek; Byungheon Lee; Hyun-Shik Lee; Tae-Yong Shin; Gil-Saeng Jeong; Sang-Hyun Kim
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

Review 9.  Roles of Immune Cells in Hereditary Angioedema.

Authors:  Anne Lise Ferrara; Leonardo Cristinziano; Angelica Petraroli; Maria Bova; Maria Celeste Gigliotti; Simone Marcella; Luca Modestino; Gilda Varricchi; Mariantonia Braile; Maria Rosaria Galdiero; Giuseppe Spadaro; Stefania Loffredo
Journal:  Clin Rev Allergy Immunol       Date:  2021-05-29       Impact factor: 8.667

10.  IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.

Authors:  Dimity H Ball; Lamyaa Al-Riyami; William Harnett; Margaret M Harnett
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.